Olive Union

Olive Union

Offers well-designed, functional, affordable wearables for impaired hearing. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD77m (Public information from Apr 2021)
Company register number 3208800464
Seoul South Korea (HQ)
  • Edit
DateInvestorsAmountRound

$141k

Seed

N/A

Seed

$10.0m

Series A

$7.0m

Valuation: $50.0m

Series B
N/A

$28.8m

-
Total FundingAUD71.0m

Recent News about Olive Union

Edit
More about Olive Unioninfo icon
Edit

Olive Union is a pioneering company in the hearing aid industry, focusing on developing innovative products to combat hearing loss and difficulty hearing for all ages. The company operates in the healthcare technology market, offering a range of hearing amplifiers and aids that are both affordable and stylish. Olive Union's core product, the Olive Smart Ear, is a single-ear hearing amplifier designed to improve everyday sound quality and is customizable to individual hearing needs. The company aims to remove the stigma associated with impaired hearing by making their devices as accepted and ubiquitous as glasses and other wearables.

Olive Union serves a diverse clientele, including individuals with varying degrees of hearing loss, from mild to severe. The company’s business model revolves around direct-to-consumer sales through their website and other online platforms, ensuring accessibility to a global market. Revenue is generated through the sale of their hearing devices and related accessories.

By focusing on affordability, design, and accessibility, Olive Union is positioned to capture a significant share of the hearing aid market, which is expanding due to an aging population and increased awareness of hearing health.

Keywords: hearing amplifiers, affordable hearing aids, customizable hearing, healthcare technology, direct-to-consumer, hearing loss solutions, stylish wearables, global market, innovative products, hearing health.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.